Health Needs::Search Drugs

Home

Health News

Themes

Blog

Testimonials

Blood Bank

About Us

testing

Indication & Dosage

Intravenous

SUSCEPTIBLE INFECTIONS

Adult: 0.5-1 g every 8 hr.

Intravenous

SUSCEPTIBLE INFECTIONS

Child: Neonate: <7 days: 20 mg/kg 12 hrly (severe infection 40 mg/kg 12 hrly); 7-28 days: 20 mg/kg 8 hrly (severe infection 40 mg/kg 8 hrly). 1-3 mth: 10 mg/kg 8 hrly; >3 mth and <50 kg: 10-20 mg/kg 8 hrly.

Intravenous

MENINGITIS

Adult: 0.5-1 g every 8 hr.

Intravenous

MENINGITIS

Child: 0.5-1 g every 8 hr.

Intravenous

SKIN AND SKIN STRUCTURE INFECTIONS

Child: 0.5-1 g every 8 hr.

Intravenous

SKIN AND SKIN STRUCTURE INFECTIONS

Adult: 0.5-1 g every 8 hr.

Max Dosage: 500 mg

Intravenous

INTRA-ABDOMINAL INFECTIONS

Child: 0.5-1 g every 8 hr.

Intravenous

INTRA-ABDOMINAL INFECTIONS

Adult: 0.5-1 g every 8 hr.

Precautions

History of hypersensitivity to carbapenem, pencillins or other β-lactam antibiotics; infants <3 mth; renal insufficiency; neurological disorders; pregnancy, lactation. Not recommended for use in MRSA.

Potentially Life-threatening
Adverse Drug Reactions

Diarrhoea, nausea, vomiting, abdominal pain; headache; constipation; rash, pruritus, uticaria; apnoea; phlebitis, thrombophlebitis, swelling and pain at inj site; disturbances in LFTs (may cause increases in serum transaminases, alkaline phosphatase, lactic dehydrogenase). Rarely: erythema multiforme; eosinophilia, thrombocytopenia, leucopenia, neutropenia; seizures and CNS effects reported in patients with underlying CNS disorders or renal impairment.

Adverse Drug Reactions

Anaphylaxis; pseudomembranous colitis; Stevens-Johnsons sydrome.

Interactions

Serum levels may be increased by probenecid. May reduce serum valproic acid levels; sub-therapeutic levels may be reached in some patients.

Webmaster:- o3sa.co.in